"Beyond the Skin: Uncovering Mycosis Fungoides and Sézary Syndrome" is a one-hour live webinar in the SSBMT Webinar Series from the Saudi Society of Blood & Marrow Transplantation (SSBMT). It focuses on the diagnosis and management of mycosis fungoides and Sézary syndrome, the two main forms of cutaneous T-cell lymphoma (CTCL).
When and how
The webinar runs on Saturday 14 November 2026, 8:00–9:00 PM KSA time (17:00 UTC). It is delivered live on Zoom. Registration is through the official Zoom webinar form, which asks for job title, institution, SCFHS ID (or NA), category (physician or non-physician), mobile, city and country.
Speaker and moderator
- Speaker: Dr. Musa Alzahrani, MD, Assistant Professor and Consultant Hematologist, King Saud University Hospital, Riyadh.
- Moderator: Dr. Mohsen Alzahrani, Section Head, Division of Stem Cell Transplant and Cellular Therapy, Department of Oncology, King Abdulaziz Medical City – Riyadh (MNGHA).
Programme (KSA time)
- 8:00–8:05 PM: Introduction and welcome remarks — Dr. Mohsen Alzahrani
- 8:05–8:45 PM: Beyond the Skin: Uncovering Mycosis Fungoides and Sézary Syndrome — Dr. Musa Alzahrani
- 8:45–9:00 PM: Discussion and Q&A — all
Why it matters
Mycosis fungoides is the most common cutaneous T-cell lymphoma. It is often confused with benign skin conditions in its early stages, so diagnosis can be delayed. Sézary syndrome is its rarer leukaemic counterpart, with erythroderma and circulating malignant T cells. Both need close teamwork between haematology, oncology, dermatology and pathology. The session is relevant to haematologists, oncologists, dermatologists, transplant physicians, pathologists, trainees and nurses who care for patients with lymphoma.
Support and credits
The official flyer shows Kyowa Kirin's logo alongside SSBMT, so this session is industry-supported. No CME/CPD accreditation is stated in the announcement or on the registration page.
More from SSBMT
The SSBMT website lists further upcoming society activities, including another webinar on 28 November 2026 and later meetings in 2027.
